Global Erectile Dysfunction (ED) Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	163 Pages	TechNavio	November, 2023	INF18310312

Best Price Guarantee
Price	from $2,500
Length	163 Pages
Publisher	TechNavio
Published Date	November, 2023
SKU	INF18310312

Global Erectile Dysfunction (ED) Drugs Market 2024-2028

The erectile dysfunction (ED) drugs market is forecasted to grow by USD 1439.39 mn during 2023-2028, accelerating at a CAGR of 6.67% during the forecast period. The report on the erectile dysfunction (ED) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for ED drugs, rising awareness of ED, and high prevalence of conditions resulting in ED.

Technavio's erectile dysfunction (ED) drugs market is segmented as below:

By End-user

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Product

Oral drugs
Topical drugs
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the presence of novel drug formulations in late stages of development as one of the prime reasons driving the erectile dysfunction (ED) drugs market growth during the next few years. Also, expanding research for development of novel therapies and increasing OTC abuse of drugs will lead to sizable demand in the market.

The report on the erectile dysfunction (ED) drugs market covers the following areas:

Erectile dysfunction (ED) drugs market sizing
Erectile dysfunction (ED) drugs market forecast
Erectile dysfunction (ED) drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading erectile dysfunction (ED) drugs market vendors that include Bayer AG, Cadila Pharmaceuticals Ltd., Cipla Ltd., Dong A Socio Holdings Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Futura Medical plc, Innovcare Lifesciences Pvt. Ltd., Lupin Ltd., Pfizer Inc., SK Inc., Teva Pharmaceutical Industries Ltd., TTK Healthcare Ltd., Viatris Inc., and VIVUS LLC. Also, the erectile dysfunction (ED) drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Product; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global erectile dysfunction (ED) drugs market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global erectile dysfunction (ed) drugs market 2018 - 2022 ($ million); 4.2 End-user Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Product Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 30: Chart on End-user - Market share 2023-2028 (%); Exhibit 31: Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Exhibit 32: Chart on Comparison by End-user; Exhibit 33: Data Table on Comparison by End-user; 6.3 Hospital pharmacy - Market size and forecast 2023-2028; Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%); 6.4 Retail pharmacy - Market size and forecast 2023-2028; Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%); 6.5 Online pharmacy - Market size and forecast 2023-2028; Exhibit 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million); Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Exhibit 46: Market opportunity by End-user ($ million); Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product: 7.1 Market segments; Exhibit 48: Chart on Product - Market share 2023-2028 (%); Exhibit 49: Data Table on Product - Market share 2023-2028 (%); 7.2 Comparison by Product; Exhibit 50: Chart on Comparison by Product; Exhibit 51: Data Table on Comparison by Product; 7.3 Oral drugs - Market size and forecast 2023-2028; Exhibit 52: Chart on Oral drugs - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on Oral drugs - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on Oral drugs - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Oral drugs - Year-over-year growth 2023-2028 (%); 7.4 Topical drugs - Market size and forecast 2023-2028; Exhibit 56: Chart on Topical drugs - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Topical drugs - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Topical drugs - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Topical drugs - Year-over-year growth 2023-2028 (%); 7.5 Others - Market size and forecast 2023-2028; Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Product; Exhibit 64: Market opportunity by Product ($ million); Exhibit 65: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Canada - Market size and forecast 2023-2028; Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 107: Market opportunity By Geographical Landscape ($ million); Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 Bayer AG; Exhibit 115: Bayer AG - Overview; Exhibit 116: Bayer AG - Business segments; Exhibit 117: Bayer AG - Key news; Exhibit 118: Bayer AG - Key offerings; Exhibit 119: Bayer AG - Segment focus; 12.4 Cadila Pharmaceuticals Ltd.; Exhibit 120: Cadila Pharmaceuticals Ltd. - Overview; Exhibit 121: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibit 122: Cadila Pharmaceuticals Ltd. - Key offerings; 12.5 Cipla Ltd.; Exhibit 123: Cipla Ltd. - Overview; Exhibit 124: Cipla Ltd. - Business segments; Exhibit 125: Cipla Ltd. - Key news; Exhibit 126: Cipla Ltd. - Key offerings; Exhibit 127: Cipla Ltd. - Segment focus; 12.6 Dr Reddys Laboratories Ltd.; Exhibit 128: Dr Reddys Laboratories Ltd. - Overview; Exhibit 129: Dr Reddys Laboratories Ltd. - Business segments; Exhibit 130: Dr Reddys Laboratories Ltd. - Key offerings; Exhibit 131: Dr Reddys Laboratories Ltd. - Segment focus; 12.7 Eli Lilly and Co.; Exhibit 132: Eli Lilly and Co. - Overview; Exhibit 133: Eli Lilly and Co. - Product / Service; Exhibit 134: Eli Lilly and Co. - Key news; Exhibit 135: Eli Lilly and Co. - Key offerings; 12.8 Endo International Plc; Exhibit 136: Endo International Plc - Overview; Exhibit 137: Endo International Plc - Business segments; Exhibit 138: Endo International Plc - Key news; Exhibit 139: Endo International Plc - Key offerings; Exhibit 140: Endo International Plc - Segment focus; 12.9 Futura Medical plc; Exhibit 141: Futura Medical plc - Overview; Exhibit 142: Futura Medical plc - Product / Service; Exhibit 143: Futura Medical plc - Key offerings; 12.10 Innovcare Lifesciences Pvt. Ltd.; Exhibit 144: Innovcare Lifesciences Pvt. Ltd. - Overview; Exhibit 145: Innovcare Lifesciences Pvt. Ltd. - Product / Service; Exhibit 146: Innovcare Lifesciences Pvt. Ltd. - Key offerings; 12.11 Lupin Ltd.; Exhibit 147: Lupin Ltd. - Overview; Exhibit 148: Lupin Ltd. - Product / Service; Exhibit 149: Lupin Ltd. - Key news; Exhibit 150: Lupin Ltd. - Key offerings; 12.12 Pfizer Inc.; Exhibit 151: Pfizer Inc. - Overview; Exhibit 152: Pfizer Inc. - Product / Service; Exhibit 153: Pfizer Inc. - Key news; Exhibit 154: Pfizer Inc. - Key offerings; 12.13 SK Inc.; Exhibit 155: SK Inc. - Overview; Exhibit 156: SK Inc. - Product / Service; Exhibit 157: SK Inc. - Key offerings; 12.14 Teva Pharmaceutical Industries Ltd.; Exhibit 158: Teva Pharmaceutical Industries Ltd. - Overview; Exhibit 159: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key news; Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibit 162: Teva Pharmaceutical Industries Ltd. - Segment focus; 12.15 TTK Healthcare Ltd.; Exhibit 163: TTK Healthcare Ltd. - Overview; Exhibit 164: TTK Healthcare Ltd. - Business segments; Exhibit 165: TTK Healthcare Ltd. - Key offerings; Exhibit 166: TTK Healthcare Ltd. - Segment focus; 12.16 Viatris Inc.; Exhibit 167: Viatris Inc. - Overview; Exhibit 168: Viatris Inc. - Business segments; Exhibit 169: Viatris Inc. - Key news; Exhibit 170: Viatris Inc. - Key offerings; Exhibit 171: Viatris Inc. - Segment focus; 12.17 VIVUS LLC; Exhibit 172: VIVUS LLC - Overview; Exhibit 173: VIVUS LLC - Product / Service; Exhibit 174: VIVUS LLC - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 175: Inclusions checklist; Exhibit 176: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 177: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 178: Research methodology; Exhibit 179: Validation techniques employed for market sizing; Exhibit 180: Information sources; 13.5 List of abbreviations; Exhibit 181: List of abbreviations; Exhibits:; Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Product; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global erectile dysfunction (ed) drugs market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on End-user - Market share 2023-2028 (%); Exhibits31: Data Table on End-user - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by End-user ($ million); Exhibits47: Data Table on Market opportunity by End-user ($ million); Exhibits48: Chart on Product - Market share 2023-2028 (%); Exhibits49: Data Table on Product - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Product; Exhibits51: Data Table on Comparison by Product; Exhibits52: Chart on Oral drugs - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Oral drugs - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Oral drugs - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Oral drugs - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Topical drugs - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Topical drugs - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Topical drugs - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Topical drugs - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits64: Market opportunity by Product ($ million); Exhibits65: Data Table on Market opportunity by Product ($ million); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits107: Market opportunity By Geographical Landscape ($ million); Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits109: Impact of drivers and challenges in 2023 and 2028; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: Bayer AG - Overview; Exhibits116: Bayer AG - Business segments; Exhibits117: Bayer AG - Key news; Exhibits118: Bayer AG - Key offerings; Exhibits119: Bayer AG - Segment focus; Exhibits120: Cadila Pharmaceuticals Ltd. - Overview; Exhibits121: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibits122: Cadila Pharmaceuticals Ltd. - Key offerings; Exhibits123: Cipla Ltd. - Overview; Exhibits124: Cipla Ltd. - Business segments; Exhibits125: Cipla Ltd. - Key news; Exhibits126: Cipla Ltd. - Key offerings; Exhibits127: Cipla Ltd. - Segment focus; Exhibits128: Dr Reddys Laboratories Ltd. - Overview; Exhibits129: Dr Reddys Laboratories Ltd. - Business segments; Exhibits130: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits131: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits132: Eli Lilly and Co. - Overview; Exhibits133: Eli Lilly and Co. - Product / Service; Exhibits134: Eli Lilly and Co. - Key news; Exhibits135: Eli Lilly and Co. - Key offerings; Exhibits136: Endo International Plc - Overview; Exhibits137: Endo International Plc - Business segments; Exhibits138: Endo International Plc - Key news; Exhibits139: Endo International Plc - Key offerings; Exhibits140: Endo International Plc - Segment focus; Exhibits141: Futura Medical plc - Overview; Exhibits142: Futura Medical plc - Product / Service; Exhibits143: Futura Medical plc - Key offerings; Exhibits144: Innovcare Lifesciences Pvt. Ltd. - Overview; Exhibits145: Innovcare Lifesciences Pvt. Ltd. - Product / Service; Exhibits146: Innovcare Lifesciences Pvt. Ltd. - Key offerings; Exhibits147: Lupin Ltd. - Overview; Exhibits148: Lupin Ltd. - Product / Service; Exhibits149: Lupin Ltd. - Key news; Exhibits150: Lupin Ltd. - Key offerings; Exhibits151: Pfizer Inc. - Overview; Exhibits152: Pfizer Inc. - Product / Service; Exhibits153: Pfizer Inc. - Key news; Exhibits154: Pfizer Inc. - Key offerings; Exhibits155: SK Inc. - Overview; Exhibits156: SK Inc. - Product / Service; Exhibits157: SK Inc. - Key offerings; Exhibits158: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits159: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits160: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits161: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits162: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits163: TTK Healthcare Ltd. - Overview; Exhibits164: TTK Healthcare Ltd. - Business segments; Exhibits165: TTK Healthcare Ltd. - Key offerings; Exhibits166: TTK Healthcare Ltd. - Segment focus; Exhibits167: Viatris Inc. - Overview; Exhibits168: Viatris Inc. - Business segments; Exhibits169: Viatris Inc. - Key news; Exhibits170: Viatris Inc. - Key offerings; Exhibits171: Viatris Inc. - Segment focus; Exhibits172: VIVUS LLC - Overview; Exhibits173: VIVUS LLC - Product / Service; Exhibits174: VIVUS LLC - Key offerings; Exhibits175: Inclusions checklist; Exhibits176: Exclusions checklist; Exhibits177: Currency conversion rates for US$; Exhibits178: Research methodology; Exhibits179: Validation techniques employed for market sizing; Exhibits180: Information sources; Exhibits181: List of abbreviations